Abstract: An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

Abstract: An article may include a material having a surface containing at least one zinc oxide and/or salt, and at least one antioxidant. A method of using a mixture including at least one zinc oxide and/or salt, and at least one antioxidant, as bacteriostatic agent may include: applying the mixture to a surface of an article.

Abstract: An implantable medical device may include a coating layer that includes a nanostructured hydroxyapatite doped with zinc ions and functionalized with lactoferrin. A process for coating an implantable medical device may include: providing an electrolytic bath; immersing a cathode and an anode in the electrolytic bath, the cathode including the implantable medical device; and allowing direct electric current to pass through the electrolytic bath so as to obtain electrolytic deposition on the implantable medical device of nanostructured hydroxyapatite doped with zinc ions. The electrolytic bath may include calcium ions, phosphate ions, and the zinc ions. The electrolytic bath also may include lactoferrin. The process may further include depositing lactoferrin on the implantable medical device coated with the nanostructured hydroxyapatite doped with the zinc ions.

Abstract: The invention relates to a process for treating an asbestos-containing material, which enables the asbestos to be transformed into inert products (i.e. not hazardous to human health) that can possibly be reused as raw materials for subsequent industrial processing or as directly marketable industrial products. The process comprising the steps of preparing an acidic solution/suspension by subjecting a food industry waste material to mixed bacterial and fungal growth and/or fermentation, and treating an asbestos-containing material with the acidic solution/suspension obtained from the mixed fermentation at a temperature of 120-170° C. and pressure of 2-10 bar.

Abstract: A composition, comprising: at least one polyhydroxyalkanoate (PHA); and at least one calcium phosphate. The at least one calcium phosphate is in a form of aggregates having an average size greater than or equal to 0.1 micron (?m) and less than or equal to 10 ?m.

Abstract: The invention relates to a process for treating an asbestos-containing material, which enables the asbestos to be transformed into inert products (i.e. not hazardous to human health) that can possibly be reused as raw materials for subsequent industrial processing or as directly marketable industrial products. The process comprising the steps of preparing an acidic solution/suspension by subjecting a food industry waste material to mixed bacterial and fungal growth and/or fermentation, and treating an asbestos-containing material with the acidic solution/suspension obtained from the mixed fermentation at a temperature of 120-170° C. and pressure of 2-10 bar.

Abstract: The invention relates to polymers selected from among polypropylene (PP), polycarbonate (PC), acrylonitrile-butadiene-styrene (ABS), polyvinylchloride (PVC) and polyethylene terephthalate (PET), nylon and polystyrene, having antibacterial properties, wherein the antibacterial effect is obtained by adding a zinc salt selected from among: zinc PCA, zinc oxide, zinc hydroxide, zinc pyrrolidone or zinc pyrithione during the process of polymerization of the monomers. The antibacterial polymers are used to prepare products intended to enter into contact with the skin.

Abstract: A dental care product comprising carbonate-substituted fluoro-hydroxyapatite particles having the formula: Ca(10-z-y-m)ZnxSryMm(PO4)(6-z)(CO3)z(OH)2-wFw wherein M is selected from the group comprising Mg, Se, K and mixtures thereof; x is a number comprised between 0 and 0.02; y is a number comprised between 0.0010 and 0.015; m is a number between 0 and 0.5; z is a number comprised between 0.0010 and 0.010 and w is a number comprised between 0.000002 and 0.0001; wherein said fluoro-hydroxyapatite particles have a crystallinity degree CD comprised between 50 and 85%.

Abstract: The present invention refers to oral care and oral hygiene products having photocatalytic activity comprising particles of a calcium phosphate compound, superficially functionalised with TiO2 nanoparticles in crystalline form, said TiO2 nanoparticles having: a) a substantially lamellar morphology; b) an aspect ratio (AR) comprised between 5 and 30; c) a surface structure having face (001) as outermost face of the crystalline lattice; and d) wherein the TiO2 is in the form of anatase, optionally mixed with rutile and/or brookite.

Abstract: The present invention refers to oral care and oral hygiene products having photocatalytic activity comprising particles of a calcium phosphate compound, superficially functionalised with TiO2 nanoparticles in crystalline form, said TiO2 nanoparticles having: a) a substantially lamellar morphology; b) an aspect ratio (AR) comprised between 5 and 30; c) a surface structure having face (001) as outermost face of the crystalline lattice; and d) wherein the TiO2 is in the form of anatase, optionally mixed with rutile and/or brookite.

Abstract: The invention relates to polymers selected from among polypropylene (PP), polycarbonate (PC), acrylonitrile-butadiene-styrene (ABS), polyvinylchloride (PVC) and polyethylene terephthalate (PET), nylon and polystyrene, having antibacterial properties, wherein the antibacterial effect is obtained by adding a zinc salt selected from among: zinc PCA, zinc oxide, zinc hydroxide, zinc pyrrolidone or zinc pyrithione during the process of polymerization of the monomers. The antibacterial polymers are used to prepare products intended to enter into contact with the skin.

Abstract: The invention relates to biologically active nanoparticles of a carbonate-substituted non-stoichiometric hydroxyapatite, having: a) a crystallinity degree CD lower than 40%, the crystallinity degree being defined as CD=(1?X/Y)·100 wherein: Y=height of the diffraction maximum at 2?=33°, X=height of the diffraction background at 2?=33° of the nanoparticles X-ray diffraction pattern; b) a length L ranging from 20 to 200 nm and a width W ranging from 5 to 30 nm; and c) an aspect ratio AR comprised between 2 and 40, the aspect ratio being defined as AR=L/W. The biologically active nanoparticles of the invention find a preferred use in oral or dental hygiene applications and may be formulated as compositions for oral or dental hygiene such as, for example, solutions, suspensions, oils, gels or other solid products.

Abstract: The invention relates to biologically active nanoparticles of a carbonate-substituted non-stoichiometric hydroxyapatite, having: a) a crystallinity degree CD lower than 40%, the crystallinity degree being defined as CD=(1?X/Y)·100 wherein: Y=height of the diffraction maximum at 2?=33°, X=height of the diffraction background at 2?=33° of the nanoparticles X-ray diffraction pattern; b) a length L ranging from 20 to 200 nm and a width W ranging from 5 to 30 nm; and c) an aspect ratio AR comprised between 2 and 40, the aspect ratio being defined as AR=L/W. The biologically active nanoparticles of the invention find a preferred use in oral or dental hygiene applications and may be formulated as compositions for oral or dental hygiene such as, for example, solutions, suspensions, oils, gels or other solid products.

Abstract: Carbonate hydroxyapatites containing magnesium, composite materials consisting of said hydroxyapatites and natural polymers are described; processes for the preparation of said materials and their use in orthopaedics and dentistry fields are also described.